The Impact of Obesity and Nutrition on Chronic Liver Diseases, An Issue of Clinics in Liver Disease PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Impact of Obesity and Nutrition on Chronic Liver Diseases, An Issue of Clinics in Liver Disease PDF full book. Access full book title The Impact of Obesity and Nutrition on Chronic Liver Diseases, An Issue of Clinics in Liver Disease by Zobair Younossi. Download full books in PDF and EPUB format.
Author: Zobair Younossi
Publisher: Elsevier Health Sciences
ISBN: 0323266657
Category : Medical
Languages : en
Pages : 297
Get Book Here
Book Description
Internationally renowned experts present topics related to obesity, nutrition, and liver disease in this issue. In the first article, the epidemiology of obesity and its association with liver disease are covered. The following two articles focus on the roles that visceral adipose tissue and microbiota potentially play in the pathogenesis of obesity-related liver disease. The next article focuses on the hepatic pathology seen in patients with obesity-related liver disease and those with malnutrition. The next five articles are focused on NAFLD and provide in-depth data on the natural history and treatment strategies for patients with NAFLD. The next six articles deal with the impact of obesity on other liver diseases and on special populations including children and liver-transplant recipients. The final article provides the most updated information regarding genomics and genetic targets that may provide better prognostic and diagnostic biomarkers and more personalized treatment targets for patients with NAFLD. Cutting-edge information in this issue will help readers gain better understanding of the natural history and pathogenesis of primary and secondary liver diseases associated with obesity. As the information about obesity-related liver disease expands, clinicians will be able to provide more targeted therapeutic options for these patients and develop more accurate diagnostic and prognostic biomarkers.
Author: Zobair Younossi
Publisher: Elsevier Health Sciences
ISBN: 0323266657
Category : Medical
Languages : en
Pages : 297
Get Book Here
Book Description
Internationally renowned experts present topics related to obesity, nutrition, and liver disease in this issue. In the first article, the epidemiology of obesity and its association with liver disease are covered. The following two articles focus on the roles that visceral adipose tissue and microbiota potentially play in the pathogenesis of obesity-related liver disease. The next article focuses on the hepatic pathology seen in patients with obesity-related liver disease and those with malnutrition. The next five articles are focused on NAFLD and provide in-depth data on the natural history and treatment strategies for patients with NAFLD. The next six articles deal with the impact of obesity on other liver diseases and on special populations including children and liver-transplant recipients. The final article provides the most updated information regarding genomics and genetic targets that may provide better prognostic and diagnostic biomarkers and more personalized treatment targets for patients with NAFLD. Cutting-edge information in this issue will help readers gain better understanding of the natural history and pathogenesis of primary and secondary liver diseases associated with obesity. As the information about obesity-related liver disease expands, clinicians will be able to provide more targeted therapeutic options for these patients and develop more accurate diagnostic and prognostic biomarkers.
Author: Zobair Younossi
Publisher: Elsevier
ISBN: 9780323266642
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
Internationally renowned experts present topics related to obesity, nutrition, and liver disease in this issue. In the first article, the epidemiology of obesity and its association with liver disease are covered. The following two articles focus on the roles that visceral adipose tissue and microbiota potentially play in the pathogenesis of obesity-related liver disease. The next article focuses on the hepatic pathology seen in patients with obesity-related liver disease and those with malnutrition. The next five articles are focused on NAFLD and provide in-depth data on the natural history and treatment strategies for patients with NAFLD. The next six articles deal with the impact of obesity on other liver diseases and on special populations including children and liver-transplant recipients. The final article provides the most updated information regarding genomics and genetic targets that may provide better prognostic and diagnostic biomarkers and more personalized treatment targets for patients with NAFLD. Cutting-edge information in this issue will help readers gain better understanding of the natural history and pathogenesis of primary and secondary liver diseases associated with obesity. As the information about obesity-related liver disease expands, clinicians will be able to provide more targeted therapeutic options for these patients and develop more accurate diagnostic and prognostic biomarkers.
Author: Cynthia Levy
Publisher: Elsevier Health Sciences
ISBN: 1455771996
Category : Medical
Languages : en
Pages : 244
Get Book Here
Book Description
Dr. Levy is a key leader in the field of hepatology , and she has enlisted authors who are top experts in their fields to submit state-of-the-art clinical reviews on cholestatic liver diseases. Articles are devoted to genetic determinants of cholestasis, nuclear receptors as drug targets, drug-induced cholestasis, primary sclerosing cholangitis, therapeutic advances in primary biliary cirrhosis, overlap syndromes, autoimmune sclerosing cholangitis, secondary sclerosing cholangitis, Focus is also on familial cholestasis, allagile syndrome and other hereditary causes of cholestasis, Systemic causes of cholestasis, advances in pathogenesis and treatment of pruritus, care of the cholestatic patient, and transplantation for cholestatic diseases . Readers will come away with a full overview of the diagnosis and treatment of cholestatic liver diseases.
Author: Tarik Asselah
Publisher: Elsevier Health Sciences
ISBN: 0323186270
Category : Medical
Languages : en
Pages : 175
Get Book Here
Book Description
The Guest Editors have assembled top international experts to present clinical reviews on the most current data being utilized in the diagnosis, treatment, and management of HBV. In fact, the most recent EASL meeting fndings are included in many of the articles. Special focus is given to Results of Treatment of Chronic Hepatitis B with Pegylated Interferon; Impact of Therapy on the Long Term Outcome of Chronic Hepatitis B; HBsAg Quantification: Clinical; HBV Infection and Hepatocellular Carcinoma; HIV-HBV Co-Infection: An Update; Hepatitis Delta: The Rediscovery; and Treatment of Patients with HBV Related Decompensated Cirrhosis and Liver Transplanted Patients
Author: Sabrina Alves Fernandes
Publisher: Frontiers Media SA
ISBN: 283255475X
Category : Medical
Languages : en
Pages : 197
Get Book Here
Book Description
There is exponential growth of new cases of chronic liver disease worldwide. Even with the advances related to the treatment of viral hepatitis, this epidemiological scenario can be explained with a significant increase in obesity, alcoholism and physical inactivity. Nutrition plays a fundamental role as a promoting agent in the prevention of fatty liver diseases and hepatocellular carcinoma, as well as in the treatment of liver diseases related to metabolic alterations and as an adjuvant treatment in the most diverse complications characteristic of cirrhosis. The nutritional management of patients with chronic liver diseases, regardless of etiology, is still a challenge. There are numerous gaps to be understood in the context of body composition, biomarkers, and dietary strategies in the face of the pathophysiology of cirrhosis.
Author: Kalyan Ram Bhamidimarri
Publisher: Elsevier Health Sciences
ISBN: 032332035X
Category : Medical
Languages : en
Pages : 265
Get Book Here
Book Description
A number of areas within liver transplant continue to evolve as the field matures. The advent of increasingly effective therapy for HCV will dramatically reduce the burden of recurrent disease within the next few years. HCC has become a well established indication for transplant with an increasing emphasis on adjuvant therapies to reduce the risk of tumor recurrence and potentially expand the acceptable limits of tumor burden amenable to liver transplant. Renal dysfunction is a frequent complication of decompensated liver disease and an important predictor of diminished post-transplant survival. Newer approached to therapy including terlipressin will reduce the impact of renal dysfunction in liver transplant candidates and potentially reduce the need for combined liver/kidney transplant. Increasing attention is being paid to role of comorbidities such as diabetes and hypertension on long-term recipient outcomes. Retransplantation remains a challenge with a variety of models available to predict outcomes. Cardiac disease pretransplant is an area of active investigation with newer entities such as cirrhotic cardiomyopathy a growing concern. These are some of many evolving issues in liver transplant which will be addressed to update our readers and which in turn will enhance the care of patients with liver disease.
Author: Scott Kahan
Publisher: Elsevier Health Sciences
ISBN: 0323477070
Category : Medical
Languages : en
Pages : 195
Get Book Here
Book Description
This issue of Medical Clinics, guest edited by Drs. Scott Kahan and Robert Kushner, is devoted to Practice-Based Nutrition Care. Articles in this outstanding issue include: Principles and Practice of Nutrition Assessment in Primary Care; Principles and Practice of Nutrition Counseling and Behavioral Medicine in Primary Care; Nutrition for the Prevention of Chronic Disease; Nutrition Recommendations in Pregnancy and Lactation; Nutrition Recommendations in Children; Nutrition Recommendations in Elderly and Aging; Nutrition Interventions for Cardiovascular Disease; Nutrition Interventions for Renal Disease; Nutrition Interventions for Diabetes Mellitus and Metabolic Syndrome; Nutrition Interventions for Chronic Liver Disease and NAFLD; Nutrition Interventions for Obesity; and Nutrition Interventions for Cancers.
Author: David Bernstein
Publisher: Elsevier Health Sciences
ISBN: 0323569870
Category : Medical
Languages : en
Pages :
Get Book Here
Book Description
Obesity has devastating effects on a patient's overall health, with specific negative effects on organ systems, long-term. The hepatologist must often manage diseases of the liver and pancreas as a result of obesity. This issue will provide a current update on the diagnosis, treatment, and management of NAFLD and NASH. Dr. Bernstein has assembled the top leaders in the field to provide timely clinical reviews. Articles are devoted to the following topics: Clinical and economic burden of NAFLD/NASH; NAFLD/NASH in children and its implications; Natural history of NAFLD/NASH; Diagnosis and evaluation of NAFLD/NASH; Radiological imaging in NAFLD/NASH; The use of liver biopsy in NAFLD: When to biopsy and in whom; Pathophysiology of NAFLD/NASH; Risk factors for the development of NAFLD/NASH including genetics; Role of intestinal microbes in NAFLD/NASH; NAFLD/NASH and the metabolic syndrome; NAFLD/NASH and lipid and insulin resistance; NAFLD/NASH and cardiac disease; Current treatment of NAFLD/NASH; Emerging treatment of NAFLD/NASH; NAFLD/NASH and HCC and NAFLD/NASH and liver transplantation. Readers will have a clear understanding of how to manage outcomes for these patients.
Author: James N. Woodruff
Publisher: Elsevier Health Sciences
ISBN: 032344623X
Category : Medical
Languages : en
Pages : 249
Get Book Here
Book Description
Obstetrician Gynecologists are frequently responsible for management of the primary care needs of their patients. A survey performed in 2005 found an estimated 37% of, non-pregnant patients, relies on gynecologists for routine primary care. The same study found that almost a quarter of gynecologists reported they needed additional primary care training across a broad set of medical topics (Acad Med. 2007; 82:602–607). The impetus for training in primary care skills is increasing. In response to language in the Affordable Care Act, the Institute of Medicine developed a report on clinical preventative services necessary for women (Clinical Preventative Services for Women: Closing the Gaps IOM. 2011; also Current Opinion in Obstetrics and Gynecology 2011, 23:471–480). The US Department of Health and Human services has adopted these IOM recommendations and, as a result, health plans are required to include these services. While initiatives such as the American Congress of Obstetricians and Gynecologists’ Well-Woman Task Force and recent cross-specialty ACOG educational collaborations have begun to address supplemental educational needs, additional resources covering key primary care topics are necessary. This issue of Obstetrics and Gynecology Clinics is an ideal means for accomplishing this important goal.
Author: Arun J. Sanyal
Publisher: Elsevier Health Sciences
ISBN: 0323682049
Category : Medical
Languages : en
Pages : 193
Get Book Here
Book Description
Together with Consulting Editor Dr. Alan Buchman, Drs. Arun J. Sanyal and Mohammad Siddiqui have put together a comprehensive issue devoted to fatty liver disease for the gastroenterologist. Expert authors have contributed clinical review articles on the following topics: Burden of disease due to NAFLD; Genetic risk factors and disease modifiers of NASH; How to identify the patient with NASH who will progress to cirrhosis; Similarities and Differences between cirrhosis due to NASH versus other etiologies; Impications of NASH as the etiology of end stage liver disease prior to and after liver transplantation; Why do lifestyle recommendations fail in most patients; Rational nutritional therapeutics for NAFLD; Recruitment and retention strategies in long-term trials for NASH; Managing extrahepatic comorbidities in NAFLD; The current status of noninvasive tools for the assessment of NAFLD; and Pharmacological Treatment strategies for NASH. Readers will come away with the information they need to improve outcomes in patients with fatty liver disease.
